Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarilumab in TNF-refractory rheumatoid arthritis – synovial tissue and MRI study
2024-514201-61-00Phase 4Authorised
- Sponsor
- Cliniques universitaires Saint-Luc
- Start
- Jul 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of sarilumab in rheumatoid arthritis (RA), sponsored by Cliniques universitaires Saint-Luc. Planned start Jul 2024; status: authorised.
02
Drugs
sarilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2024-514201-61-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514201-61-00.